Gland Pharma Ltd. (GLAND)
Market Closed
12 Aug, 10:00
XNSE XNSE Primary MSE ₹
2,891. 20
-33.2
-1.1353%
₹
- Market Cap
- P/E Ratio
- Div Yield
732,462 Volume
- Eps
₹ 2,924.4
Previous Close Want to track GLAND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 14.39 | 16.98 |
| | | 12.97 | 11.15 |
| | | 13.28 | - |
| | | 12.17 | 12.42 |
| | | 10.75 | 9.93 |
| | | 13.99 | - |
| | | 13.32 | - |
| | | 14.01 | 11.65 |
| | | 14.33 | - |
| | | 11.92 | - |
GLAND Earnings Reports FAQ
What is the earnings per share (EPS) for GLAND?
EPS data for GLAND is currently not available, as Gland Pharma Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately 45.75%, reflecting the GLAND's performance and XNSE market conditions.
When is the next earnings release date?
Gland Pharma Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Gland Pharma Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GLAND at this time, as Gland Pharma Ltd has no recent EPS data to calculate it.
